ACCUTASE: A Breakthrough In Recovering T-Cells From 3D Scaffolds

Biotechnology
1

Recently, IIT Bombay has developed and demonstrated a gentler version for recovering lab-grown T cells from 3D scaffolds. This is particularly relevant to CAR (Chimeric Antigen Receptor) T-cell therapy for treating cancer, but is also useful in other immunotherapy and tissue engineering research. Traditionally, Simple Manual Flushing and Harsh Enzymatic Digestion were the methods used for this purpose.

What is CAR T-cell Therapy?

This therapy treats blood cancers by using the patient’s own immune cells, specifically T-cells, and modifying them to recognize and attack cancer cells.

Step-by-Step Process:

  • Leukapheresis: Collecting T-cells from the patient’s blood using an apheresis machine and sending them to a laboratory
  • Lymphodepleting Chemotherapy: To reduce the patient’s existing lymphocytes in their body to create an optimal environment for the modified T-cells to multiply
  • CAR T-cell Manufacturing: Chimeric Antigen Receptor T-cells are manufactured
  • Infusion: CAR T-cells are administered into the patient’s bloodstream

Understanding CAR T-Cell Therapy
Understanding CAR T-Cell Therapy1536Ă—1024 203 KB

Why is Accutase Better than Traditional Methods in Recovering T-cells from Scaffolds?

  • Accutase works as a gentler enzymatic dissociation
  • Keeping the CAR T-cells intact without destroying them
  • Higher cell recovery
  • Better cell sustainability

Why Accutase is Better Than Traditional Methods for Recovering Lab-Grown T-Cells from 3D Scaffolds
Why Accutase is Better Than Traditional Methods for Recovering Lab-Grown T-Cells from 3D Scaffolds1402Ă—1122 228 KB

Do you think immune-based therapies are the future of disease treatment?

1 Like
2

Interesting advancement in immunotherapy research.

1 Like
3

Informative

1 Like
4

Really interesting advancement. Improving T-cell recovery while maintaining cell integrity could make therapies like CAR T-cell treatment more effective and accessible in the future. Immune-based therapies definitely seem promising, especially with innovations like these that focus on both efficiency and cell sustainability.

1 Like